Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471284 · ClinicalTrials.gov registry record · NA
Recruitment Messages for Current Smokers Recently Diagnosed With Cancer
A NA study of Health Behavior and Tobacco Smoking, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT05471284: Completed NA study of Health Behavior and Tobacco Smoking, sponsored by University of Oklahoma.
NCT05471284 is a NA study of Health Behavior and Tobacco Smoking that has completed, run by University of Oklahoma. The registered enrollment target is 99 participants, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05471284, a NA study of Health Behavior and Tobacco Smoking, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 different message frames across evaluation, effectiveness, and outcome measures. We combine findings from a message design experiment with textual analytic software to provide a holistic understanding of how message frames may or may not differentially affect tobacco treatment trial participation within the context of a cancer diagnosis.
Primary Outcome
The main effect within each message factor level was examined using ANOVA and compared with the control condition.
Conditions Studied
Interventions
- BEHAVIORAL Proximal
- BEHAVIORAL Distal
- BEHAVIORAL Cost
- BEHAVIORAL Benefit
- BEHAVIORAL Loss
Study Locations (1)
Oklahoma
- Jordan Neil - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2019-04-02 |
| Phase | NA |
What the finished NCT05471284 record still lists
NCT05471284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Health Behavior appearing as the primary indexed condition, and to 5 interventions - of which Proximal is the first listed.
NCT05471284 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05471284 about?
NCT05471284 is a clinical study titled "Recruitment Messages for Current Smokers Recently Diagnosed With Cancer". The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 diff...
What is the current status of trial NCT05471284?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2019-02-11. Estimated completion is 2019-04-02.
What conditions does trial NCT05471284 study?
This clinical trial studies the following conditions: Health Behavior, Tobacco Smoking.
What interventions are being tested in trial NCT05471284?
The interventions under investigation include: Proximal (BEHAVIORAL), Distal (BEHAVIORAL), Cost (BEHAVIORAL), Benefit (BEHAVIORAL), Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT05471284?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05471284 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05471284's enrollment target sits among peer trials
99 47th of 65 higher than 19 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI